Tetraphase Pharmaceuticals Inc Asset Turnover Ratio (TTPH), as of first quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tetraphase Pharmaceuticals Inc  (NASDAQ: TTPH)
 

Tetraphase Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Tetraphase Pharmaceuticals Inc asset turnover ratio, the ability of Tetraphase Pharmaceuticals Inc's assets to generate revenue in the first quarter 2020, increased sequentially to 0.17 in the first quarter (Mar 31 2020), TTPH's balance sheet remain strong.

Within sector 166 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2020, to 3385, from total ranking in the fourth quarter 2019 at 4008.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TTPH Asset Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Asset Change -68.23 % -74.34 % -66.73 % -30.59 % -15.44 %
Y / Y Revenue Change 37.86 % -60.54 % 190.18 % -90.73 % -32.68 %
Asset Turnover Ratio (TTM) 0.17 0.11 0.11 0.07 0.16
TTPH's Total Ranking # 3385 # 4008 # 3595 # 3781 # 3437
Seq. Asset Change 10.16 % -14.92 % -56.13 % -22.73 % -11.02 %
Seq. Revenue Change 3.85 % -49.4 % 211.28 % -15.71 % -70.28 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 167
Healthcare Sector # 470
Overall Market # 3385

Asset Turnover Ratio Statistics
High Average Low
0.16 0.08 0.03
(Mar 31 2019)   (Dec 31 2016)




TTPH Company Profile • Back to TTPH Efficiency Comparisons • Compare TTPH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2020 Assets at quarter ending Mar 31 2020
Sanuwave Health Inc   0.62 $ 1.499  Millions$ 2.414  Millions
Stablecoin Development Corporation  0.62 $ 7.000  Millions$ 11.292  Millions
Avantor Inc   0.62 $ 6,079.200  Millions$ 9,835.075  Millions
Camp4 Therapeutics Corporation  0.62 $ 366.107  Millions$ 592.338  Millions
Atrion Corporation  0.61 $ 157.046  Millions$ 256.991  Millions
Iradimed Corporation  0.61 $ 38.757  Millions$ 63.628  Millions
Neuronetics Inc   0.61 $ 61.404  Millions$ 100.883  Millions
Vertex Pharmaceuticals Inc  0.61 $ 4,819.493  Millions$ 7,939.922  Millions
Bioadaptives Inc   0.60 $ 0.013  Millions$ 0.022  Millions
Cantel Medical Corp   0.60 $ 1,022.153  Millions$ 1,694.921  Millions
Sangui Biotech International Inc  0.60 $ 0.046  Millions$ 0.077  Millions
Nuvasive Inc  0.60 $ 1,153.175  Millions$ 1,937.743  Millions
Logicmark Inc  0.59 $ 16.700  Millions$ 28.166  Millions
Summit Therapeutics Inc   0.59 $ 43.640  Millions$ 74.044  Millions
Eli Lilly And Company  0.59 $ 23,087.100  Millions$ 39,237.100  Millions
Aveo Pharmaceuticals Inc   0.59 $ 27.968  Millions$ 47.642  Millions
Crh Medical Corporation  0.58 $ 116.721  Millions$ 201.024  Millions
Neogen Corporation  0.58 $ 418.858  Millions$ 721.531  Millions
Steris Plc  0.58 $ 3,030.895  Millions$ 5,260.339  Millions
Jrsis Health Care Corp  0.57 $ 29.879  Millions$ 52.100  Millions
Merck and Co Inc   0.57 $ 48,081.000  Millions$ 84,151.500  Millions
Merit Medical Systems Inc  0.57 $ 1,000.028  Millions$ 1,751.142  Millions
Charles River Laboratories International inc   0.57 $ 2,723.716  Millions$ 4,775.657  Millions
Avid Bioservices Inc   0.57 $ 59.702  Millions$ 105.039  Millions
Agilent Technologies inc   0.57 $ 5,236.000  Millions$ 9,246.000  Millions
Akorn Inc  0.56 $ 721.251  Millions$ 1,283.359  Millions
Zoetis Inc   0.56 $ 6,339.000  Millions$ 11,332.750  Millions
Amphastar Pharmaceuticals Inc   0.56 $ 327.255  Millions$ 586.685  Millions
Regeneron Pharmaceuticals Inc   0.55 $ 7,979.800  Millions$ 14,418.900  Millions
Exagen Inc   0.55 $ 40.711  Millions$ 73.646  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.